About Leucine-rich repeat-containing protein 28
Leucine-rich repeat-containing protein 28 (LRRC28) is a protein
from Homo sapiens identified by UniProt accession
Q86X40, 367 residues long.
MolForge cross-references it against 0 known binders and
19 disease associations.
Target properties
| Protein name | Leucine-rich repeat-containing protein 28 |
| UniProt accession | Q86X40 |
| Gene | LRRC28 |
| Organism | Homo sapiens |
| Length | 367 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (19)
Diseases linked to this target (Open Targets).
- FEV/FVC ratio · score 0.41
- neurodegenerative disease · score 0.21
- gestational age · score 0.11
- parental genotype effect measurement · score 0.11
- hemoglobin measurement · score 0.09
- hematocrit · score 0.08
- red blood cell density measurement · score 0.07
- mean corpuscular hemoglobin concentration · score 0.07
- erythrocyte count · score 0.07
- Varicose veins · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q86X40-F1 | alphafold | PREDICTED | 90.22 | — |
Amino-acid sequence (367 residues)
MASELCKTIS VARLEKHKNL FLNYRNLHHF PLELLKDEGL QYLERLYMKR NSLTSLPENL AQKLPNLVEL YLHSNNIVVV PEAIGSLVKL QCLDLSDNAL EIVCPEIGRL RALRHLRLAN NQLQFLPPEV GDLKELQTLD ISTNRLLTLP ERLHMCLSLQ YLTVDRNRLW YVPRHLCQLP SLNELSMAGN RLAFLPLDLG RSRELQYVYV DNNIHLKGLP SYLYNKVIGC SGCGAPIQVS EVKLLSFSSG QRTVFLPAEV KAIGTEHDHV LPLQELAMRG LYHTYHSLLK DLNFLSPISL PRSLLELLHC PLGHCHRCSE PMFTIVYPKL FPLRETPMAG LHQWKTTVSF VAYCCSTQCL QTFDLLS
Explore Leucine-rich repeat-containing protein 28 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets